Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 18 to 60

Allopurinol for Depression in Adults on Sertraline

Official title: Allopurinol Adjuvant Therapy in Patients With Major Depressive Disorder

Run by Tanta University · NCT07574060 · Data updated 2026-11-12

This trial tests whether adding allopurinol to sertraline helps adults with major depressive disorder who haven’t fully responded to first-line treatment.

More Depression trials

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment70 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta)
StatusRecruiting
StartedMay 20, 2026
Main results expectedMay 20, 2027
Study endsMay 20, 2027
Registry record updatedAugust 18, 2026
Trial IDNCT07574060 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with major depressive disorder who have a HAM-D score of at least 10 and are not diagnosed with bipolar disorder or the specified exclusions.

Probably not a fit

Patients with bipolar disorder, pregnancy, significant cardiovascular or kidney disease, eating disorders, or those not able to take birth control may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of combining allopurinol with sertraline in adults with major depressive disorder. Participants will receive sertraline 50 mg plus allopurinol 300 mg and will be monitored for changes in depressive symptoms and tolerability. The trial includes adults with a HAM-D score of 10 or higher and excludes those with bipolar disorder, eating disorders, pregnancy, cardiovascular issues, or severe kidney problems. It is conducted at Tanta University under a non-commercial collaboration.

Why it matters

Potential benefit: If successful, this combination could offer a new option for patients who do not fully respond to standard antidepressants.

How similar studies have gone: There is limited published data on allopurinol added to antidepressants, so this study explores a relatively novel combination.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients aged greater than 18 years old. Patients with a HAM-D score of at least 10 with item 1, depressed mood, scoring 2 or greater, are eligible.

Exclusion Criteria:

Patients with bipolar I or bipolar II disorder Patients with eating disorders Pregnant women or women not using medically accepted means of birth control Cardiovascular disorders Severe renal impairment

Where it's running

  • Tanta Unuversity
    Tanta, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.